By otakuyassine3@gmail.com 
Canoe Financial LP acquired a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 243 shares of the insurance provider’s stock, valued at approximately $62,000.
A number of other institutional investors also recently added to or reduced their stakes in the stock. FNY Investment Advisers LLC lifted its holdings in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after purchasing an additional 26,856 shares during the last quarter. PDT Partners LLC increased its position in Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after buying an additional 2,660 shares in the last quarter. Ontario Teachers Pension Plan Board raised its stake in Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after buying an additional 71,910 shares during the last quarter. Swedbank AB boosted its holdings in Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after acquiring an additional 3,085 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of Humana during the third quarter worth about $948,000. Institutional investors own 92.38% of the company’s stock.
Humana Stock Performance
Shares of HUM stock opened at $282.63 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $415.73. The business’s 50 day moving average is $273.92 and its two-hundred day moving average is $308.67. The company has a market capitalization of $34.03 billion, a P/E ratio of 25.03, a P/E/G ratio of 2.02 and a beta of 0.55.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Analysts expect that Humana Inc. will post 16.14 EPS for the current fiscal year.
Humana Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. Humana’s dividend payout ratio is currently 31.36%.
Insider Activity at Humana
In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.29% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. TD Cowen raised their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Royal Bank of Canada dropped their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Morgan Stanley upped their target price on Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Wells Fargo & Company lowered their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $302.70.
Check Out Our Latest Stock Analysis on Humana
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana and related companies with MarketBeat.com’s FREE daily email newsletter.